Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 3,54 Md
0,56%0,64%18.4x2.08x3.96x10.22x11.85x 70,75 Md
0,58%0,6%26.88x4.06x5.56x16.35x20.27x 54,35 Md
-.--%-.--%36.02x7.41x12.31x23.42x27.4x 47,19 Md
3,21%3,29%-47.07x2.64x3.33x9.85x11.49x 42,48 Md
-.--%-.--%30.86x1.91x3.49x11.63x14.06x 30,91 Md
-.--%-.--%57.4x4.37x3.57x25.12x24.64x 25,76 Md
-.--%-.--%-6.29x3.82x8.71x-5.35x-5.01x 21,62 Md
-.--%0,05%64.77x5.82x6.36x43.76x49.37x 19,91 Md
-.--%-.--%-37.55x-6.66x17.86x-48.89x-56.5x 16,33 Md
-.--%-.--%24.82x3.65x5.32x13.85x19.25x 16,9 Md
-.--%-.--%-110.32x12045.55x11.84x-84.78x-118.16x 11,7 Md
-.--%-.--%18.17x - 3.71x14.35x16.76x 11,86 Md
0,18%0,19%51.69x21.08x31.22x44.15x45.53x 10,43 Md
-.--%-.--%48.64x - - - - 10,71 Md
3,1%2,86%13.41x1.26x1.92x7.91x10.54x 7,09 Md
-.--%-.--%64.06x7.91x6.21x34.4x46.28x 6,31 Md
0,35%0,41%29.32x - 7.9x20.96x25.03x 5,99 Md
Moyenne 0,47% 0,47% 16,66x 864,63x 8,33x 8,56x 8,92x 22,99 Md
Moyenne pondérée par Capi. 0,57% 0,59% 15,88x 373,02x 7,03x 10,94x 12,20x
Biopharmacies